AGEN
AGEN
NASDAQ · Biotechnology

Agenus Inc

$6.95
+0.08 (+1.16%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +448.6% upside
Low Target $23.34
Average Target $38.13
High Target $40.06
Current Price $6.95
Current
$6.95
Target
$38.13
$23.34 $38.13 avg $40.06
Scenario Analysis
Bear Case
$23.34
235.8%
Low target
Base Case
$38.13
+448.6%
Avg target
Bull Case
$40.06
+476.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$10.31
-32.6% from high
52-Week Low
$2.71
+156.5% from low
Target vs 52W High
$38.13
+269.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%